Pulmonary Function Tests: Forced Expiratory Volume in 1 Second (FEV 1)

FEV 1
With the help of well-trained and experienced pulmonary function technicians, children as young as 4 to 5 years of age should be capable of performing spirometry. Spirometry measures forced vital capacity (FVC), forced expiratory volume in 1 second (FEV 1 ), the ratio of FEV 1 /FVC, as well as other measures of airflow including the forced expiratory flow between 25% and 75% of FVC (FEF 25–75 ). The FEV 1 is the most commonly used and reproducible measure of pulmonary function, whereas the FEF 25–75 demonstrates much more intrapatient variability. (more…)

Treg Cells In Allergen-Specific Immunotherapy

treg cells
Treg cells or regulatory T cells constitute a large population of cellular infiltrate in atopic/allergic inflammation and a dysregulated immune response appears to be an important pathogenetic factor. Cardinal events during allergic inflammation can be classified as activation, organ-selective homing, survival and reactivation, and effector functions of immune system cells. T cells are activated by aeroallergens, food antigens, autoantigens, and bacterial exotoxins superantigens in allergic inflammation. They are under the influence of the skin, lung, or nose-related chemokine network and show organ-selective homing. (more…)

Antimicrobial Enzymes and Binding Proteins

antimicrobial enzymes
A few of the best known humoral effectors of innate immunity are listed in Table 1 bellow, along with the types of target molecules they recognize. Some are enzymes that can directly injure or kill microbial pathogens. An example is lysozyme, an endoglycosidase found in human saliva, mucus, tears, and other secretions, which attacks the protective cell wall encasing every bacterial cell. Lysozyme acts by digesting the peptidoglycan meshwork formed by long carbohydrate chains of alternating N-acetylmuramic acid and N-acetylglucosamine residues, crosslinked covalently by short oligopeptide sidechains which is a major constituent of all bacterial cell walls but is not found in mammalian tissues. (more…)

Anti IgE Therapy Tolerability with Omalizumab Therapy in Allergic Asthma Patients

Anti IgE Therapy
Anti-IgE therapy could be particularly beneficial for patients with concomitant asthma and rhinitis as it targets a common factor in the two diseases. Omalizumab is significantly more efficacious than placebo in preventing asthma exacerbations and in improving disease-related quality of life scores when added to standard asthma and rhinitis therapies. (more…)

Effect Of Pet Removal On Pet Allergic Asthma

Allergen avoidance has been recommended in the management of allergic asthma children. Very few studies have assessed the effect of pet removal on pet allergic asthma. The authors examined the effect of pet removal from homes on pulmonary function testing, bronchial
hyper-responsiveness and medication use. This was a prospective, controlled but non-randomized and open study. Subjects included 20 symptomatic patients with newly diagnosed pet allergic asthma who were keeping domestic animals, including hamsters, cats, dogs and ferrets, and were sensitized to these animals. (more…)

Primary Immunodeficiencies: Antibody Deficiency and Immunoglobulin Replacement Therapy

Primary immunodeficiencies occur with a frequency approaching that of cystic fibrosis (1:2500 live births). However, because they are perceived to be very rare and usually present with common infections, they are under-diagnosed. Often the diagnosis is not considered until substantial end-organ damage has occurred, by which time definitive treatment is only partially successful in preventing further infections. (more…)

The Canadian Childhood Asthma Primary Prevention Study

Avoidance of any one of the individual risk factors associated with childhood asthma has not been successful in preventing its development. The purpose of this study was to determine the effectiveness of a multifaceted intervention programme for the primary prevention of asthma in high-risk infants at 7 years of age. Five hundred and forty-five high-risk infants with an immediate family history of asthma and allergies were prospectively randomized into intervention and control groups pre-natally. (more…)

Oral Food Challenges & Relationship to Allergen-Specific IgE Levels

Diagnosis of food hypersensitivity is a clinical challenge and the only current definitive test is the Double Blind Placebo-Controlled Food Challenges. Although the Double Blind Placebo-Controlled Food Challenges is the current gold standard, it is difficult to perform and is very time-consuming. Hence, researchers are continually evaluating new tests and assessing the value of the available serum tests. (more…)

Asthma With Concomitant Allergic Rhinitis Among Asthmatic Children

Asthmatic children who also have Allergic Rhinitis seem to have higher morbidity and to use more healthcare resources. This was further investigated to determine the incremental effect of Allergic Rhinitis on healthcare resource use in children with asthma. The data were from a general practice database in the UK and covered the period 1998–2001. Children aged 6–15 years who had an asthma related visit to their general practitioner at least once during a defined 12 month period were reviewed. (more…)

SAP Gene Defects In Male Patients Diagnosed With Common Variable Immunodeficiency

The molecular basis of Common Variable Immunodeficiency (CVID) is unknown and the diagnosis requires the exclusion of other diseases known to cause primary antibody deficiency syndromes, such as X-linked lymphoproliferative disease (XLP). XLP is a rare primary immunodeficiency disease in which severe immune dysregulatory phenomena occur, typically after exposure to Epstein–Barr virus (EBV). The defective gene in XLP is SAP (SLAM associated protein, where SLAM is signalling lymphocyte activation molecule), a small SH2 domain containing protein involved in signal transduction events downstream of the SLAM family of receptors. (more…)

Next Page »